Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

17%(1 trials)

Phase Distribution

Ph not_applicable

17%

Ph phase_2

33%

Ph phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

3(50.0%)

Phase 2Efficacy & side effects

2(33.3%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (50.0%)

Phase 22 (33.3%)

N/A1 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn®

NCT01063920

completedphase_1

Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation

NCT00750243

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT03351439Not Applicable

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Completed

NCT02351024Phase 1

Phase I Study PK Study With OXP005 and Naprosyn

Completed

NCT01229228Phase 2

Study of Naproxen Capsules to Treat Dental Pain

Completed

NCT01063920Phase 2

Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn®

Completed

NCT00750243Phase 1

Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation

Completed

NCT00992381Phase 1

Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn Alone

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6